http://glamclinicdubai.ae/en/weight-loss/wegovy-injections/
In Dubai, Wegovy, containing semaglutide, is a breakthrough for obesity treatment, offering hope for weight loss. Understanding its workings, expectations, and regulatory context is vital for safe use.

Wegovy, a weekly injectable with semaglutide, mimics GLP-1 to regulate appetite and blood sugar. It suppresses hunger, delays stomach emptying, and aids blood sugar control.

For Dubai residents, knowing who can benefit from Wegovy is crucial. Adults with BMI over 30 or BMI 27-30 with weight-related issues are eligible. Adolescents with high BMI percentile can also use it alongside diet and exercise.

Before starting Wegovy, a consultation with a licensed healthcare provider is mandatory. Screening for certain conditions is necessary, and dosage escalation is gradual to minimize side effects.

Self-injection training and proper storage are essential. Gastrointestinal symptoms are common, managed with diet adjustments. Any severe side effects should be reported promptly.

Wegovy is generally not covered by insurance in Dubai, so be prepared for out-of-pocket costs. Lifestyle changes are key for success, and regular follow-ups are necessary for monitoring progress.

By understanding these points, Dubai residents can embark on a safe and effective weight loss journey with Wegovy under professional guidance.